Literature DB >> 26641630

Targeting Innate Immunity with dsRNA-Conjugated Mesoporous Silica Nanoparticles Promotes Antitumor Effects on Breast Cancer Cells.

Amelia Ultimo1,2, Cristina Giménez1,2, Pavel Bartovsky1,2, Elena Aznar1,2, Félix Sancenón1,2, M Dolores Marcos1,2, Pedro Amorós3, Ana R Bernardo4, Ramón Martínez-Máñez5,6, Ana M Jiménez-Lara7, José R Murguía1,2.   

Abstract

We describe herein a Toll-like receptor 3 (TLR3) targeting delivery system based on mesoporous silica nanoparticles capped with the synthetic double stranded RNA polyinosinic-polycytidylic acid (poly(I:C)) for controlled cargo delivery in SK-BR-3 breast carcinoma cells. Our results show that poly(I:C)-conjugated nanoparticles efficiently targeted breast cancer cells due to dsRNA-TLR3 interaction. Such interaction also triggered apoptotic pathways in SK-BR-3, significantly decreasing cells viability. Poly(I:C) cytotoxic effect in breast carcinoma cells was enhanced by loading nanoparticles' mesopores with the anthracyclinic antibiotic doxorubicin, a commonly used chemotherapeutic agent.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antitumor agents; breast carcinoma; drug delivery; mesoporous gated materials; polyinosinic-polycytidylic acid

Mesh:

Substances:

Year:  2016        PMID: 26641630     DOI: 10.1002/chem.201504629

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  3 in total

1.  Poly(I:C) transfection induces a pro-inflammatory cascade in murine mammary carcinoma and fibrosarcoma cells.

Authors:  A Sales Conniff; G Encalada; S Patel; M Bhandary; F Al-Takrouri; L Heller
Journal:  RNA Biol       Date:  2022-01       Impact factor: 4.766

2.  Functional Magnetic Mesoporous Silica Microparticles Capped with an Azo-Derivative: A Promising Colon Drug Delivery Device.

Authors:  Adrián H Teruel; Carmen Coll; Ana M Costero; Daniel Ferri; Margarita Parra; Pablo Gaviña; Marta González-Álvarez; Virginia Merino; M Dolores Marcos; Ramón Martínez-Máñez; Félix Sancenón
Journal:  Molecules       Date:  2018-02-10       Impact factor: 4.411

3.  Toll-like receptor 3 -926T>A increased the risk of breast cancer through decreased transcriptional activity.

Authors:  Lei Fan; Peng Zhou; Ao-Xiang Chen; Guang-Yu Liu; Ke-Da Yu; Zhi-Ming Shao
Journal:  Oncoimmunology       Date:  2019-10-15       Impact factor: 8.110

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.